Bottom line
How much do PRHSX and SCHLX overlap?
72% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 55.6% of PRHSX's assets and 59.7% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
PRHSX holds far more positions (279 vs 65), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and SCHLX have in common
| Holding | % of PRHSX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 13.85% | 13.85% |
| Johnson & Johnson | 6.63% | 6.19% | 6.19% |
| Unitedhealth Group Inc | 5.99% | 5.73% | 5.73% |
| Abbvie Inc | 5.10% | 4.90% | 4.90% |
| Merck & Co. Inc. | 4.01% | 4.85% | 4.01% |
| Gilead Sciences Inc | 2.82% | 2.78% | 2.78% |
| Thermo Fisher Scientific Inc | 2.52% | 3.46% | 2.52% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.45% | 2.28% |
| Bristol-myers Squibb Co | 2.11% | 1.50% | 1.50% |
| Abbott Laboratories | 1.89% | 2.39% | 1.89% |
| Intuitive Surgical Inc | 1.87% | 2.69% | 1.87% |
| Amgen Inc | 1.82% | 2.88% | 1.82% |
| Stryker Corp | 1.78% | 2.61% | 1.78% |
| Danaher Corp | 1.43% | 2.13% | 1.43% |
| Cardinal Health Inc | 1.03% | 1.34% | 1.03% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Elevance Health Inc — 1.53%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.23%
- Royalty Pharma Plc- Cl A — 0.97%
- Cvs Health Corp — 0.94%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
- Brightspring Health Services — 0.82%
Only in SCHLX
- AstraZeneca PLC — 3.80%
- Novartis AG — 2.90%
- Boston Scientific Corp — 2.10%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Regeneron Pharmaceuticals Inc — 1.43%
- Cencora Inc — 1.26%
- Roche Holding AG — 1.24%
- Pfizer Inc — 1.17%
Asset mix
| Asset type | PRHSX | SCHLX |
|---|---|---|
| Stocks | 96.4% | 99.6% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 0.7% | 0.5% |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | PRHSX | SCHLX |
|---|---|---|
| US | 92.6% | 85.7% |
| CH | 0.5% | 5.2% |
| GB | 1.7% | 3.8% |
| DK | 0.7% | 1.7% |
| IE | 0.8% | 1.5% |
| FR | 0.2% | 1.0% |
| NL | 1.0% | 1.0% |
| BM | 0.7% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PRHSX and SCHLX overlap?
What stocks do PRHSX and SCHLX have in common?
Should I own both PRHSX and SCHLX?
Which holds more stocks, PRHSX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.